Healthcare investors backing India's science economy.
Fund III is an India-focused vehicle. We invest US$10 million and above at Series A and Series B into drug discovery, pharma manufacturing, MedTech, HealthTech and AI-driven biotechnology companies built by Indian founders and Indian-origin operators worldwide.
What we fund in India
Small-molecule and biologics drug discovery platforms with validated preclinical or clinical data, including computer-aided drug discovery (CADD) and AI-native pipelines.
Pharmaceutical manufacturing and CDMO capacity serving regulated markets, where India's cost base and regulatory maturity create durable global share.
MedTech and device technology companies with CE or CDSCO clearance and a credible path to FDA, plus HealthTech businesses with proven unit economics rather than subsidised growth.
Why India, and why now
India combines a deep scientific talent pool, regulated-market manufacturing scale and a widening domestic payer base. That combination is now producing companies capable of global outcomes rather than domestic-only returns.
We invest post product-readiness and after initial market validation, which lets us underwrite execution rather than science risk alone. Every position is supported by follow-on capital from a capped 25-company portfolio.
How we work with Indian founders
Local presence in Mumbai, Hyderabad and Chennai, with partners who sit on the ground rather than fly in for board meetings.
Support across regulatory strategy, clinical and manufacturing partnerships, international market entry, senior hiring and downstream capital introductions.
Frequently asked questions
- Which healthcare sectors does OceansGled invest in across India?
- Drug discovery, pharmaceutical manufacturing and CDMO, MedTech and device technology, HealthTech, and AI for computer-aided drug discovery.
- What is the minimum investment size for Indian companies?
- US$10 million, typically at Series A or Series B, with reserved follow-on capital for later rounds.
- Do you invest only in India-registered companies?
- No. We back India-based companies as well as Indian-origin founders building elsewhere, and we can invest through offshore or domestic structures.